| | |
A. Assessment of other state reimportation legislation and | | programs, including implementation, utilization, costs of | | administration and savings from utilization; |
|
| | | B. Analysis of the necessary steps to develop an Internet | | connection, link or website for pharmacies and wholesale | | providers of prescription drugs to uninsured or underinsured | | residents and a process for certifying those pharmacies and | | wholesale providers; |
|
| | | C. Development of procedures for ensuring the health and | | safety of participants in the reimportation program; |
|
| | | D. Review of relevant state laws and rules, including | | pharmacy licensing laws, and determination of necessary | | legislation; and |
|
| | | E. Assessment of other access, quality, safety and economic | | issues related to the design and operation of a | | reimportation program. |
|
| | | 3. The Governor's Office of Health Policy and Finance must | | provide necessary staffing services to the committee. |
|
| | | 4. The committee shall report to the Joint Standing Committee | | on Health and Human Services by January 15, 2006 or 30 days after | | the adjournment of the United States Congress, whichever occurs | | later. If the United States Congress has passed a law allowing | | drug reimportation or if the federal Centers for Medicare and | | Medicaid Services has granted a waiver application, the State | | may move forward with the development of a plan for a | | reimportation program based on the findings and recommendations | | of the committee and review by the Joint Standing Committee on | | Health and Human Services. |
|
|